MENU
SLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Silence Therapeutics (SLN) Ownership - Who owns Silence Therapeutics?
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more
Profile
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
238.75M
P/E Ratio
N/A
Total Cash
136.53M
Projected Growth
N/A
Total Debt
60K
Revenue
27.7M
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash/Share
2.89
Total Debt/Equity
N/A
Revenue/Share
0.59 USD as % of share price
Fundamentals
SLN
Capitalization
239M
P/E Ratio
N/A
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
2.89
Total Debt
60K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.59%
Revenue
27.7M
ROE
N/A
Book Value
-112.74M
P/B Ratio
1.32
Cash Flow
N/A
Earnings
-1.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
-10.29M
Current Ratio
8.81
Current Revenue Per Employee
1224.14
Dividends Per Share - Security
N/A
EBITDA
-71.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
61.97
Revenue To Assets
-33.21
Shares Held By Institutions
59.7M
Shares Outstanding - Current
47.2M
Total Liabilities
298M
Total Volume MTD
N/A
Value
1
Gain YTD
-18.459
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com